Crystal engineering of the composition of pharmaceutical phases

被引:393
作者
Walsh, RDB
Bradner, MW
Fleischman, S
Morales, LA
Moulton, B
Rodríguez-Hornedo, N
Zaworotko, MJ
机构
[1] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
[2] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
关键词
D O I
10.1039/b208574g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.
引用
收藏
页码:186 / 187
页数:2
相关论文
共 27 条
[21]   Crystallization processes in pharmaceutical technology and drug delivery design [J].
Shekunov, BY ;
York, P .
JOURNAL OF CRYSTAL GROWTH, 2000, 211 (1-4) :122-136
[22]  
Sheldrick G.M., 1996, SADABS VERSION 2008
[23]  
SHELDRICK GM, 2000, SHELXTL RELEASE 6 10
[24]  
Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO
[25]  
2-U
[26]   Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids [J].
Vishweshwar, P ;
Nangia, A ;
Lynch, VM .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (02) :556-565
[27]   Crystal engineering using anilic acids and dipyridyl compounds through a new supramolecular synthon [J].
Zaman, MB ;
Tomura, M ;
Yamashita, Y .
JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (18) :5987-5995